Gilead Sciences, Inc.

Stocks

GILD

US3755581036

Real-time Estimate Cboe BZX 18:30:33 22/09/2026 +04			5-day change	1st Jan Change
149.68 ^USD	-0.58%		+1.81%	+21.35%

09-18	Dr. Reddy's Confirms License for Gilead's Yearly-Once HIV Drug; Shares Up 2%	MT
09-17	Gilead Sciences Insider Sold Shares Worth $432,646, According to a Recent SEC Filing	MT

Transcript : Gilead Sciences, Inc. - Special Call

Published on 04/08/2026 at 03:00 am +04 - Modified on 04/08/2026 at 07:50 am +04

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good afternoon. Thank you for attending today's Gilead Sciences update on proposed Tubulis, Ouro and Arcellx acquisitions call. My name is Tamia, and I

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

Latest news about Gilead Sciences, Inc.

09-18	Dr. Reddy's Confirms License for Gilead's Yearly-Once HIV Drug; Shares Up 2%	MT
09-17	Gilead Sciences Insider Sold Shares Worth $432,646, According to a Recent SEC Filing	MT
09-16	Gilead Sciences, Inc. Expands Royalty-Free Voluntary Licensing Agreements For Lenacapavir With Dr. Reddy?s Laboratories Limited, Emcure Pharmaceuticals Limited, Eva Pharma For Pharmaceutical Industries S.A.E., Ferozsons Laboratories Limited, Hetero And Mylan Laboratories Limited	CI
09-16	Gilead Sciences Expands Licensing Agreements for HIV Treatment	MT
09-15	Gilead Sciences, Inc. and Pan American Health Organization Announce Milestone Partnership to Accelerate Access to Twice-Yearly Lenacapavir for HIV Prevention Across Latin America and the Caribbean	CI
09-15	Gilead Sciences, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 10:45 AM
09-15	Gilead Sciences Expands Lenacapavir Access to 14 Countries	MT
09-15	Gilead, PAHO agree on HIV prevention drug access in Latin America, Caribbean	RE
09-10	Gilead Sciences, Inc. Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference, Sep-10-2026 10:55 AM
09-10	HSBC Adjusts Price Target on Gilead Sciences to $175 From $155, Keeps Buy Rating	MT
09-09	Gilead Sciences, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 11:00 AM
09-09	Assembly Biosciences Exercises Option to Share US Costs, Profits for Herpes Program With Gilead	MT
09-09	Assembly Biosciences Exercises U.S. Profit-Share Option for Herpes Program With Gilead	DJ
09-09	Assembly Biosciences, Inc. and Gilead Sciences, Inc. Exercise U.S. Profit-Share Option for HSV Helicase-Primase Inhibitor Program	CI
09-08	Gilead Sciences Opens Research Center At Foster City Headquarters	CI